Skip to main content

Allogeneic processed thymus tissue Disease Interactions

There is 1 disease interaction with allogeneic processed thymus tissue.

Moderate

Allogeneic processed thymus tissue (applies to allogeneic processed thymus tissue) renal dysfunction

Moderate Potential Hazard, Moderate plausibility.

Renal dysfunction at baseline is considered a risk factor for death when using allogeneic processed thymus tissue. Ensure the involvement of a nephrologist in the care of patients with renal impairment.

References (1)
  1. (2021) "Product Information. Rethymic (allogeneic processed thymus tissue)." Enzyvant Therapeutics Inc., 1

Switch to consumer interaction data

Allogeneic processed thymus tissue drug interactions

There are 252 drug interactions with allogeneic processed thymus tissue.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer